Nottingham 2027 - Virtual National Breast Pathology Update Course
Friday 16 April 2027 – 09.30 to 16.30 UK Time
2027
Virtual National Breast Pathology Update Course
Slide Seminar
Case Histories
To view the images click individual images below or on this link: Nottingham Update Course 2025
Please complete the Mentimeter Answer Form (linked HERE) and submit them by Thursday 8th May. Two CME points can be claimed for the completed form and responses will be used to guide discussion of the cases at the course. All responses will be anonymous.
Andy Hanby

Case 1
H&E
64 yo F with a swollen red hard nipple for 4 weeks.
Case 2
H&E
55 yo F. 7×5 mm hypoechoic lesion 10 o’clock right breast ? cyst ? other. Lesion seen to reduce in size post biopsy. P1, R3
Case 3
H&E
62 yo F. Mass detected at breast screening.
Abeer Shaaban

Case 4
H&E
63 yo F. Right breast lesion. Second opinion.
Case 4
E-CAD
63 yo F. Right breast lesion. Second opinion.
Wen Ng

Case 5
H&E
56 yo F. Left breast mass, periareolar region. On macroscopy well circumscribed mass 52 mm in diameter.
Preethi Gopinath

Case 6
H&E
56 yo F. Left breast mass, periareolar region. On macroscopy well circumscribed mass 52 mm in diameter.
Case 6
ER
56 yo F. Left breast mass, periareolar region. On macroscopy well circumscribed mass 52 mm in diameter
Case 6
CK 5/6
56 yo F. Left breast mass, periareolar region. On macroscopy well circumscribed mass 52 mm in diameter
Case 6
P63
56 yo F. Left breast mass, periareolar region. On macroscopy well circumscribed mass 52 mm in diameter
Case 6
SMMHC
56 yo F. Left breast mass, periareolar region. On macroscopy well circumscribed mass 52 mm in diameter.
Preethi Gopinath

Case 7
H&E
59 yo F. 9 mm stellate lesion. VAE – B3 on core.
Case 7
SMMHC
59 yo F. 9 mm stellate lesion. VAE – B3 on core.
Case 7
P63
59 yo F. 9 mm stellate lesion. VAE – B3 on core.
Case 7
ER
59 yo F. 9 mm stellate lesion. VAE – B3 on core.
Case 7
CK 5/6
59 yo F. 9 mm stellate lesion. VAE – B3 on core.
Philip Schouten

Case 9
H&E
57 yo F. 15 mm mass. WLE.
Case 9
ER
57 yo F. 15 mm mass. WLE.
Case 9
CK 5/6
57 yo F. 15 mm mass. WLE.
Case Histories – Mentimeter Answer Form
Please complete the Mentimeter Answer Form (linked HERE) and submit them by Thursday 8th May. Two CME points can be claimed for the completed form and responses will be used to guide discussion of the cases at the course. All responses will be anonymous.
Scientific Programme
Session 1 - EQA/ Screening Session - Chair: Dr Elena Provenzano
09.30 Dr Elena Provenzano - Welcome & introduction
09.35 Professor Emad Rakha - EQA outlier cases - what pathologists find difficult
09.50 Professor Ian Ellis – EQA: digital versus glass – insights from Breast EQA
10.05 Dr Rahul Deb – NHS BSP Pathology review data
10.20 Professor Cecily Quinn – ICCR datasets; what’s new
10.35 Dr Silvana DiPalma – Prosigna testing; what has changed since Optima
10.50 Questions and Discussion
11.00 TEA BREAK
Session 2 - TNBC Session - Chair: Professor Ian Ellis
11.00 Professor Sarah Pinder - Special types of TNBC
11.40 Dr Elena Provenzano -TNBC biomarkers and neoadjuvant response
12.10 Jean Abraham (to be confirmed) - Update on oncological management of TNBC including immunotherapy and BRCA
12.40 Questions and Discussion
12.55 LUNCH BREAK
Session 3 - Slide Seminar 1 - Fibroepithelial Lesions - Chair: Professor Cecily Quinn
13.30 Puay Hoon Tan, Rebecca Millican-Slater, Cecily Quinn, Philip Schouten - 5 cases
14.30 Speaker to be confirmed - Update on surgical management of Phyllodes tumours
14.50 TEA BREAK
Session 4 - Slide Seminar 2 - Papillary Lesions and Mimics - Chair: Professor Abeer Shaaban
15.00 Abeer Shaaban, Mieke von Bockstal, Preethi Gopinath, Shauna Casey, Sue Pritchard - 6 cases
16.10 General Questions and Discussion
16.20 Ask the experts
16.30 Meeting Close
NOTE: All times are UK
CPD Approval
The Course has been approved for CPD points for the course from the Royal College of Pathologists. ALL registered attendees will receive a Certificate of Participation as a PDF within a week of the course.
Course - 5 CPD Points
Slide Case Submission - 2 CPD Points





















